Keyword Analysis & Research: edwards sapien
Keyword Research: People who searched edwards sapien also searched
Search Results related to edwards sapien on Search Engine
-
Transcatheter SAPIEN 3 Ultra | Edwards Lifesciences
https://www.edwards.com/healthcare-professionals/products-services/transcatheter-heart/transcatheter-sapien-3-ultra
WebThe Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for patients with symptomatic heart disease due to failing (stenosed, insufficient, or combined) of a surgical or transcatheter bioprosthetic aortic valve, a surgical bioprosthetic mitral valve, or a native mitral valve with an ...
DA: 21 PA: 6 MOZ Rank: 38
-
Transcatheter SAPIEN 3 | Edwards Lifesciences
https://www.edwards.com/gb/healthcare-professionals/products-services/transcatheter-heart/transcatheter-sapien-3
WebWebb J, Gerosa G, Lefèvre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64 (21):2235-2243. 3. Thourani VH, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
DA: 17 PA: 93 MOZ Rank: 46
-
Edwards SAPIEN 3 and SAPIEN 3 Ultra THV System – …
https://www.fda.gov/medical-devices/recently-approved-devices/edwards-sapien-3-and-sapien-3-ultra-transcatheter-heart-valve-system-p140031s125
WebJun 8, 2021 · The Edwards SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valve (THV) System is a catheter-based artificial heart valve system designed to replace a diseased heart valve without open-heart...
DA: 82 PA: 69 MOZ Rank: 68
-
Transcatheter SAPIEN 3 | Edwards Lifesciences
http://www.sapien3.com/
WebThe Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for patients with symptomatic heart disease due to failing (stenosed, insufficient, or combined) of a surgical or transcatheter bioprosthetic aortic valve, a surgical bioprosthetic mitral valve, or a native mitral valve with an ...
DA: 9 PA: 73 MOZ Rank: 22
-
Transcatheter pulmonary valve replacement | Edwards Lifesciences
https://www.edwards.com/healthcare-professionals/products-services/transcatheter-heart/transcatheter-sapien-3-valve-pulmonic
WebIndications: The Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent is indicated for use in the management of pediatric and adult patients with severe pulmonary regurgitation as measured by echocardiography who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for ...
DA: 15 PA: 27 MOZ Rank: 45
-
Transcatheter SAPIEN 3 Ultra | Edwards Lifesciences
https://www.edwards.com/gb/healthcare-professionals/products-services/transcatheter-heart/transcatheter-sapien-3-ultra
WebSAPIEN 3 Ultra transcatheter heart valve. Built upon the proven SAPIEN platform, the SAPIEN 3 Ultra transcatheter heart valve is designed with your patient's future needs in mind. Taller, textured outer skirt. Cobalt chromium frame.
DA: 61 PA: 27 MOZ Rank: 69
-
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE ... - Edwards Lifesciences
https://www.edwards.com/newsroom/news/2022-09-12-edwards-launches-sapien-3-ultra-resilia-valve-foll
WebIRVINE, Calif., Sept. 12, 2022 -- Edwards Lifesciences (NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve. The launch follows recent U.S. Food and Drug Administration (FDA) …
DA: 11 PA: 20 MOZ Rank: 94
-
FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE …
https://www.prnewswire.com/news-releases/five-year-data-from-partner-3-trial-demonstrate-excellent-survival-for-patients-receiving-edwards-sapien-3-valve-301965283.html
WebSAN FRANCISCO, Oct. 24, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling ...
DA: 32 PA: 87 MOZ Rank: 54
-
EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH …
https://www.edwards.com/newsroom/news/2021-12-20-edwards-receives-fda-approval-for-sapien-3-with-al
WebIRVINE, Calif., Dec. 20, 2021 -- Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with severe pulmonary regurgitation.
DA: 82 PA: 56 MOZ Rank: 12